Search Results

There are 58119 results for: content related to: Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice

  1. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice

    Synapse

    Volume 35, Issue 4, 15 March 2000, Pages: 250–255, Michael R. Kilbourn, Kyle Kuszpit and Phillip Sherman

    Version of Record online : 2 FEB 2000, DOI: 10.1002/(SICI)1098-2396(20000315)35:4<250::AID-SYN2>3.0.CO;2-S

  2. Zingerone activates VMAT2 during MPP+-induced Cell Death

    Phytotherapy Research

    Volume 29, Issue 11, November 2015, Pages: 1783–1790, Jae-Sun Choi, Woom-Yee Bae, Chan Park and Joo-Won Jeong

    Version of Record online : 17 AUG 2015, DOI: 10.1002/ptr.5435

  3. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([18F]AV-133) in a MPTP-lesioned PD mouse model

    Synapse

    Volume 66, Issue 9, September 2012, Pages: 823–831, Ko-Ting Chao, Hsin-Hsin Tsao, Yi-Hsin Weng, Ing-Tsung Hsiao, Chia-Ju Hsieh, Shiaw-Pyng Wey, Tzu-Chen Yen, Mei-Ping Kung and Kun-Ju Lin

    Version of Record online : 13 JUN 2012, DOI: 10.1002/syn.21572

  4. You have free access to this content
    Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease

    Journal of Neuroendocrinology

    Volume 24, Issue 1, January 2012, Pages: 48–61, S. Al Sweidi, M. G. Sánchez, M. Bourque, M. Morissette, D. Dluzen and T. Di Paolo

    Version of Record online : 20 DEC 2011, DOI: 10.1111/j.1365-2826.2011.02193.x

  5. Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering

    Synapse

    Volume 30, Issue 2, October 1998, Pages: 205–210, Michael R. Kilbourn, Phillip Sherman and Louise C. Abbott

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2396(199810)30:2<205::AID-SYN10>3.0.CO;2-0

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  7. You have free access to this content
    Steroids-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

    CNS Neuroscience & Therapeutics

    Volume 16, Issue 3, June 2010, Pages: e43–e71, Maria Gabriela Sánchez, Mélanie Bourque, Marc Morissette and Thérèse Di Paolo

    Version of Record online : 6 MAY 2010, DOI: 10.1111/j.1755-5949.2010.00163.x

  8. Selective alterations of gene expression in mice induced by MPTP

    Synapse

    Volume 55, Issue 1, January 2005, Pages: 45–51, Z. Xu, D. Cawthon, K.A. McCastlain, W. Slikker Jr. and S.F. Ali

    Version of Record online : 21 OCT 2004, DOI: 10.1002/syn.20089

  9. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  10. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  11. You have free access to this content
    VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease

    Journal of Neurochemistry

    Volume 105, Issue 1, April 2008, Pages: 78–90, Ming-Kai Chen, Hiroto Kuwabara, Yun Zhou, Robert J. Adams, James R. Brašić, Jennifer L. McGlothan, Tatyana Verina, Neal C. Burton, Mohab Alexander, Anil Kumar, Dean F. Wong and Tomás R. Guilarte

    Version of Record online : 6 NOV 2007, DOI: 10.1111/j.1471-4159.2007.05108.x

  12. Oestrogens Prevent Loss of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter (VMAT2) in Substantia Nigra of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice

    Journal of Neuroendocrinology

    Volume 17, Issue 8, August 2005, Pages: 509–517, S. Jourdain, M. Morissette, N. Morin and T. Di Paolo

    Version of Record online : 1 JUL 2005, DOI: 10.1111/j.1365-2826.2005.01337.x

  13. Neuroimaging biomarkers for Parkinson disease: Facts and fantasy

    Annals of Neurology

    Volume 76, Issue 6, December 2014, Pages: 769–783, Joel S. Perlmutter and Scott A. Norris

    Version of Record online : 7 NOV 2014, DOI: 10.1002/ana.24291

  14. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  15. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  16. You have free access to this content
    Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model

    Brain Pathology

    Volume 25, Issue 4, July 2015, Pages: 377–390, Anderson H.F.F. Leão, Aldair J. Sarmento-Silva, José R. Santos, Alessandra M. Ribeiro and Regina H. Silva

    Version of Record online : 22 APR 2015, DOI: 10.1111/bpa.12253

  17. Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry

    Medicinal Research Reviews

    Volume 31, Issue 4, July 2011, Pages: 483–519, Kandatege Wimalasena

    Version of Record online : 4 FEB 2010, DOI: 10.1002/med.20187

  18. Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?

    European Journal of Neuroscience

    Volume 35, Issue 12, June 2012, Pages: 1894–1907, Hanna S. Lindgren and Stephen B. Dunnett

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1460-9568.2012.08162.x

  19. Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease

    Annals of Neurology

    Volume 43, Issue 5, May 1998, Pages: 555–560, Dr George R. Uhl

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410430503

  20. Poster session 1: A. Basic science, genetics, neuropharmacology, Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S17–S64,

    Version of Record online : 21 OCT 2002, DOI: 10.1002/mds.10349